Anupriya Agarwal
Title
Cited by
Cited by
Year
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
AS Corbin, A Agarwal, M Loriaux, J Cortes, MW Deininger, BJ Druker
The Journal of clinical investigation 121 (1), 396-409, 2011
7342011
Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase.
AK Agarwal, C Monder, B Eckstein, PC White
Journal of Biological Chemistry 264 (32), 18939-18943, 1989
5501989
The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization.
GM Tannin, AK Agarwal, C Monder, MI New, PC White
Journal of Biological Chemistry 266 (25), 16653-16658, 1991
5211991
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML
JE Maxson, J Gotlib, DA Pollyea, AG Fleischman, A Agarwal, CA Eide, ...
New England Journal of Medicine 368 (19), 1781-1790, 2013
4302013
Functional genomic landscape of acute myeloid leukaemia
JW Tyner, CE Tognon, D Bottomly, B Wilmot, SE Kurtz, SL Savage, ...
Nature 562 (7728), 526-531, 2018
2092018
TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms
AG Fleischman, KJ Aichberger, SB Luty, TG Bumm, CL Petersen, ...
Blood, The Journal of the American Society of Hematology 118 (24), 6392-6398, 2011
1782011
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
C Hurtz, K Hatzi, L Cerchietti, M Braig, E Park, Y Kim, S Herzog, ...
Journal of Experimental Medicine 208 (11), 2163-2174, 2011
1612011
Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response
DK Sethi, A Agarwal, V Manivel, KVS Rao, DM Salunke
Immunity 24 (4), 429-438, 2006
1162006
Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins
MA Davare, A Saborowski, CA Eide, C Tognon, RL Smith, J Elferich, ...
Proceedings of the National Academy of Sciences 110 (48), 19519-19524, 2013
1122013
Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia
A Agarwal, RJ MacKenzie, R Pippa, CA Eide, J Oddo, JW Tyner, R Sears, ...
Clinical cancer research 20 (8), 2092-2103, 2014
1022014
Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors
E Traer, R MacKenzie, J Snead, A Agarwal, AM Eiring, T O'Hare, ...
Leukemia 26 (5), 1140-1143, 2012
952012
The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition
AG Fleischman, JE Maxson, SB Luty, A Agarwal, LR Royer, ML Abel, ...
Blood, The Journal of the American Society of Hematology 122 (22), 3628-3631, 2013
842013
Identification of interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid leukemia
A Carey, CA Eide, L Newell, E Traer, BC Medeiros, DA Pollyea, ...
Cell reports 18 (13), 3204-3218, 2017
742017
Rictor regulates cell migration by suppressing RhoGDI2
NK Agarwal, CH Chen, H Cho, DR Boulbčs, E Spooner, DD Sarbassov
Oncogene 32 (20), 2521-2526, 2013
71*2013
Inhibition of NF-κB expression and allergen-induced airway inflammation in a mouse allergic asthma model by andrographolide
J Li, L Luo, X Wang, B Liao, G Li
Cellular & molecular immunology 6 (5), 381-385, 2009
662009
Absence of SKP2 expression attenuates BCR-ABL–induced myeloproliferative disease
A Agarwal, TGP Bumm, AS Corbin, T O'Hare, M Loriaux, J VanDyke, ...
Blood, The Journal of the American Society of Hematology 112 (5), 1960-1970, 2008
652008
Pesticide residue in water—a challenging task in India
A Agarwal, R Prajapati, OP Singh, SK Raza, LK Thakur
Environmental monitoring and assessment 187 (2), 54, 2015
582015
Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle
TP Braun, M Szumowski, PR Levasseur, AJ Grossberg, XX Zhu, ...
PloS one 9 (9), e106489, 2014
532014
FGF2 from marrow microenvironment promotes resistance to FLT3 inhibitors in acute myeloid leukemia
E Traer, J Martinez, N Javidi-Sharifi, A Agarwal, J Dunlap, I English, ...
Cancer research 76 (22), 6471-6482, 2016
502016
ERK2, but not ERK1, mediates acquired and “de novo” resistance to imatinib mesylate: implication for CML therapy
CI Aceves-Luquero, A Agarwal, JL Callejas-Valera, L Arias-González, ...
PloS one 4 (7), e6124, 2009
492009
The system can't perform the operation now. Try again later.
Articles 1–20